Lung Adenocarcinoma during Pregnancy: 11-Year Follow-Up

Area of Science:

• Oncology
• Radiotherapy
• Molecular Diagnostics

Background:

• Rising incidence of lung cancer in young pregnant women due to smoking and delayed childbearing.
• Importance of molecular testing for lung adenocarcinoma, especially in younger patients with potential for targetable alterations.
• Pregnancy presents unique challenges for cancer diagnosis and treatment management.

Observation:

• A case of lung adenocarcinoma diagnosed during pregnancy.
• The patient achieved long survival through a combination of treatments.
• Treatment included whole brain radiotherapy, conventional chemotherapy, and anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) targeted therapy.

Findings:

• Whole brain radiotherapy demonstrated safety during pregnancy.
• Personalized, multidisciplinary management is crucial for palliative brain metastasis cases.
• ALK TKI-targeted treatment contributed to favorable outcomes in this pregnant patient.

Implications:

• Highlights the safety and efficacy of certain cancer treatments during pregnancy.
• Emphasizes the need for molecular profiling in pregnant lung cancer patients.
• Suggests further research into optimal upfront management strategies for brain metastases in ALK-positive patients, particularly during pregnancy.